Clinical trial Recruiting at 1 site Interventional Ages 50 to 85

Comparing pain relief from two medications after knee surgery

Official title: Comparison Efficacy of Mirogabalin and Pregabalin in Total Knee Arthroplasty. a Randomized Controlled Trial

Run by Thammasat University Hospital · NCT06328062 · Data updated 2026-11-12

This study tests whether mirogabalin or pregabalin works better to relieve pain after knee surgery for people aged 50-85 with osteoarthritis.

Quick facts

Study typeInterventional
Ages50 Years to 85 Years
SexAll
Enrollment80 (estimated)
SponsorThammasat University Hospital
Academic / other
Locations1 site (Khlong Luang, Changwat Pathum Thani)
StatusRecruiting
StartedApril 1, 2024
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedAugust 7, 2026
Trial IDNCT06328062 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50-85 who are undergoing unilateral primary total knee arthroplasty due to osteoarthritis.

Probably not a fit

Patients with a glomerular filtration rate below 60, severe liver disease, or those who have had previous knee surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of two medications, mirogabalin and pregabalin, in reducing postoperative pain following unilateral primary total knee arthroplasty (TKA). Participants aged 50-85 with osteoarthritis will be randomly assigned to receive either mirogabalin or pregabalin for six weeks post-surgery. The study will evaluate pain levels and functional outcomes to determine which medication provides better pain relief after the procedure.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management options for patients undergoing knee surgery.

How similar studies have gone: Previous studies have shown promising results in pain management with gabapentinoids, making this approach a potentially valuable addition to postoperative care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 50-85 years old
2. Unilateral primary osteoarthritis undergoing primary TKA
3. ASA I-III

Exclusion Criteria:

1. GFR \<60
2. Allergy to drug in this study
3. Cannot underwent spinal anesthesia and adductor canal block
4. Taking gabapentinoid within 3 months before surgery
5. History of previous knee surgery
6. Severe liver disease

Where it's running

  • Thammasat University Hospital
    Khlong Luang, Changwat Pathum Thani, Thailand
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.